Jaguar Health (JAGX) Other Non Operating Income (2015 - 2026)
Jaguar Health (JAGX) posted quarterly Other Non Operating Income of $205000.0 for Q1 2026, up 83.04% year-over-year from $112000.0 in Q1 2025, and up 169.02% quarter-over-quarter from -$297000.0 in Q4 2025.
Jaguar Health (JAGX) Other Non Operating Income (2015 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Other Non Operating Income for 12 consecutive years, with $205000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non Operating Income rose 83.04% year-over-year to $205000.0; the TTM figure through Mar 2026 stood at $136000.0 (up 291.55% YoY), while the FY2025 annual figure was $43000.0, down 15.69% from the prior year.
- Other Non Operating Income improved to $205000.0 in Q1 2026 per JAGX's latest filing, from -$297000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $832000.0 in Q1 2022 and bottomed at -$1.1 million in Q2 2022.
- Historically, Other Non Operating Income has averaged $5562.5 across 5 years, with a median of $69000.0 in 2023.
- Annual changes were most pronounced in 2022 — Other Non Operating Income plunged 6276.47% — and 2024, when it surged 2050.0%.
- Jaguar Health's Other Non Operating Income stood at -$158000.0 in 2022, then jumped by 262.03% to $256000.0 in 2023, then surged by 47.66% to $378000.0 in 2024, then plunged by 178.57% to -$297000.0 in 2025, then soared by 169.02% to $205000.0 in 2026.
- Business Quant data shows JAGX's Other Non Operating Income at $205000.0 in Q1 2026, -$297000.0 in Q4 2025, and -$94000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Jaguar Health | 447,549.24 | -9.62 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 205,000.00 |
| Dec 31, 2025 | -297,000.00 |
| Sep 30, 2025 | -94,000.00 |
| Jun 30, 2025 | 322,000.00 |
| Mar 31, 2025 | 112,000.00 |
| Dec 31, 2024 | 378,000.00 |
| Sep 30, 2024 | 168,000.00 |
| Jun 30, 2024 | -729,000.00 |
| Mar 31, 2024 | 234,000.00 |
| Dec 31, 2023 | 256,000.00 |
| Sep 30, 2023 | -70,000.00 |
| Jun 30, 2023 | 26,000.00 |
| Mar 31, 2023 | -12,000.00 |
| Sep 30, 2022 | -158,000.00 |
| Jun 30, 2022 | -1.08 Mn |
| Mar 31, 2022 | 832,000.00 |
| Sep 30, 2021 | -20,000.00 |
| Jun 30, 2021 | -17,000.00 |
| Mar 31, 2021 | -753,000.00 |
| Dec 31, 2020 | -1.30 Mn |